Bobbi Evans
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Graduate Student Researcher
Research Areas
Biography and Research Information
OverviewAI-generated summary
Bobbi Evans' research investigates the anti-amyloid properties of curcumin and its derivatives, specifically comparing tetrahydrocurcumin to curcumin in vitro. Evans' work also explores the molecular modeling and design of novel microtubule polymerization inhibitors intended for use in treating resistant melanoma and prostate cancer. These inhibitors are designed to be metabolically stable and possess reduced toxicity. Evans' scholarly output includes two publications with a total of 24 citations and an h-index of 1. Evans was recently active in 2021.
Metrics
- h-index: 1
- Publications: 2
- Citations: 27
Selected Publications
-
Tetrahydrocurcumin Has Similar Anti-Amyloid Properties as Curcumin: In Vitro Comparative Structure-Activity Studies (2021)
Collaboration Network
Top Collaborators
- Tetrahydrocurcumin Has Similar Anti-Amyloid Properties as Curcumin: In Vitro Comparative Structure-Activity Studies
- Tetrahydrocurcumin Has Similar Anti-Amyloid Properties as Curcumin: In Vitro Comparative Structure-Activity Studies
- Tetrahydrocurcumin Has Similar Anti-Amyloid Properties as Curcumin: In Vitro Comparative Structure-Activity Studies
- Tetrahydrocurcumin Has Similar Anti-Amyloid Properties as Curcumin: In Vitro Comparative Structure-Activity Studies
- Tetrahydrocurcumin Has Similar Anti-Amyloid Properties as Curcumin: In Vitro Comparative Structure-Activity Studies
- Tetrahydrocurcumin Has Similar Anti-Amyloid Properties as Curcumin: In Vitro Comparative Structure-Activity Studies
Similar Researchers
Based on overlapping research topics